TownSquare Capital’s Co-Diagnostics CODX Stock Holding History

TownSquare Capital’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-667	Closed	-$25K	–	1498
2024 Q2	$25K	Hold	667	–	–	﹤0.01%	1285
2024 Q1	$22.4K	Hold	667	–	–	﹤0.01%	1221
2023 Q4	$26.6K	Buy	667 +264	+66%	+$9.31K	﹤0.01%	1118
2023 Q3	$12.8K	Hold	403	–	–	﹤0.01%	1095
2023 Q2	$13.4K	Sell	403 -791	-66%	-$30.3K	﹤0.01%	1051
2023 Q1	$53K	Sell	1,194 -1,047	-47%	-$83.9K	﹤0.01%	953
2022 Q4	$169K	Hold	2,241	–	–	﹤0.01%	890
2022 Q3	$216K	Buy	+2,241	New	+$313K	0.01%	677

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

TownSquare Capital's CODX Position: Q3 2024 in Review

TownSquare Capital sold out of Co-Diagnostics (CODX) in Q3 2024, closing a stake of 667 shares — an estimated $25K sold.

TownSquare Capital first reported a position in CODX in Q3 2022 and held it in 8 quarters. The position peaked at $216K in Q3 2022. 36 funds tracked by Wall St. Rank hold CODX as of Q3 2024.

TownSquare Capital reported no remaining Co-Diagnostics position as of Q3 2024 after selling out during the quarter.
TownSquare Capital sold 667 Co-Diagnostics shares in Q3 2024, an estimated $25K.
TownSquare Capital first reported a position in Co-Diagnostics in Q3 2022 and held it in 8 quarters.
TownSquare Capital's Co-Diagnostics position peaked at $216K in Q3 2022.
36 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2024.

Based on TownSquare Capital's 13F filing for Q3 2024, filed 13 Nov 2024.